(BVN) Compania de Minas - Overview
Sector: Basic MaterialsIndustry: Other Precious Metals & Mining | Exchange NYSE (USA) | Currency USD | Market Cap: 8.056m | Total Return 118.3% in 12m
Stock: Metals, Minerals, Mining, Power
Total Rating 76
Risk 71
Buy Signal 0.11
| Risk 5d forecast | |
|---|---|
| Volatility | 42.7% |
| Relative Tail Risk | -5.73% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.82 |
| Alpha | 105.21 |
| Character TTM | |
|---|---|
| Beta | 0.600 |
| Beta Downside | 1.043 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.30% |
| CAGR/Max DD | 1.60 |
EPS (Earnings per Share)
Revenue
Description: BVN Compania de Minas March 05, 2026
Compañía de Minas Buenaventura S.A.A. (BVN) is a Peruvian company involved in the full lifecycle of polymetallic ore and metal production. This includes exploration, mining, concentration, smelting, and marketing.
The company extracts gold, silver, lead, zinc, and copper. Mining operations are spread across various Peruvian provinces, including Tambomayo, Orcopampa, Uchucchacua, Julcani, and San Gabriel. BVN also holds interests in several other mines and a mining unit.
Beyond extraction, BVN operates a monohydrate manganese sulphate crystallization plant and hydroelectric power plants, diversifying its industrial activities. The company, established in 1953, is headquartered in Lima, Peru. Mining companies often vertically integrate to control costs and supply chains.
To deepen your understanding of BVNs operational specifics and financial health, further research on platforms like ValueRay is recommended.
Headlines to watch out for
- Precious metals price volatility impacts revenue
- Peruvian political instability threatens mining operations
- Operating costs influenced by energy and labor expenses
- Regulatory changes affect environmental compliance
- Copper demand from global electrification initiatives
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 784.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -1.17 > 1.0 |
| NWC/Revenue: 33.44% < 20% (prev 31.06%; Δ 2.38% < -1%) |
| CFO/TA 0.10 > 3% & CFO 580.9m > Net Income 784.7m |
| Net Debt (179.8m) to EBITDA (841.3m): 0.21 < 3 |
| Current Ratio: 2.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (254.0m) vs 12m ago 0.0% < -2% |
| Gross Margin: 48.63% > 18% (prev 0.38%; Δ 4.82k% > 0.5%) |
| Asset Turnover: 31.36% > 50% (prev 22.87%; Δ 8.49% > 0%) |
| Interest Coverage Ratio: 10.72 > 6 (EBITDA TTM 841.3m / Interest Expense TTM 65.5m) |
Altman Z'' 5.35
| A: 0.10 (Total Current Assets 1.16b - Total Current Liabilities 576.0m) / Total Assets 6.02b |
| B: 0.48 (Retained Earnings 2.90b / Total Assets 6.02b) |
| C: 0.13 (EBIT TTM 701.9m / Avg Total Assets 5.54b) |
| D: 2.19 (Book Value of Equity 3.84b / Total Liabilities 1.76b) |
| Altman-Z'' Score: 5.35 = AAA |
Beneish M -2.57
| DSRI: 1.37 (Receivables 529.4m/256.6m, Revenue 1.74b/1.15b) |
| GMI: 0.78 (GM 48.63% / 37.98%) |
| AQI: 0.92 (AQ_t 0.42 / AQ_t-1 0.46) |
| SGI: 1.50 (Revenue 1.74b / 1.15b) |
| TATA: 0.03 (NI 784.7m - CFO 580.9m) / TA 6.02b) |
| Beneish M-Score: -2.57 (Cap -4..+1) = A |
What is the price of BVN shares?
As of March 27, 2026, the stock is trading at USD 32.46 with a total of 1,892,929 shares traded.
Over the past week, the price has changed by +1.79%, over one month by -21.08%, over three months by +9.85% and over the past year by +118.33%.
Over the past week, the price has changed by +1.79%, over one month by -21.08%, over three months by +9.85% and over the past year by +118.33%.
Is BVN a buy, sell or hold?
Compania de Minas has received a consensus analysts rating of 3.33.
Therefor, it is recommend to hold BVN.
- StrongBuy: 0
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BVN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 37 | 13.9% |
| Analysts Target Price | 37 | 13.9% |
BVN Fundamental Data Overview March 25, 2026
P/E Trailing = 9.6121
P/E Forward = 36.4964
P/S = 4.6525
P/B = 1.8944
P/EG = 1.1115
Revenue TTM = 1.74b USD
EBIT TTM = 701.9m USD
EBITDA TTM = 841.3m USD
Long Term Debt = 696.7m USD (from longTermDebt, two quarters ago)
Short Term Debt = 8.93m USD (from shortTermDebt, last quarter)
Debt = 709.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 179.8m USD (from netDebt column, last quarter)
Enterprise Value = 8.24b USD (8.06b + Debt 709.7m - CCE 529.8m)
Interest Coverage Ratio = 10.72 (Ebit TTM 701.9m / Interest Expense TTM 65.5m)
EV/FCF = 78.47x (Enterprise Value 8.24b / FCF TTM 105.0m)
FCF Yield = 1.27% (FCF TTM 105.0m / Enterprise Value 8.24b)
FCF Margin = 6.05% (FCF TTM 105.0m / Revenue TTM 1.74b)
Net Margin = 45.20% (Net Income TTM 784.7m / Revenue TTM 1.74b)
Gross Margin = 48.63% ((Revenue TTM 1.74b - Cost of Revenue TTM 891.9m) / Revenue TTM)
Gross Margin QoQ = 53.39% (prev 42.89%)
Tobins Q-Ratio = 1.37 (Enterprise Value 8.24b / Total Assets 6.02b)
Interest Expense / Debt = 2.34% (Interest Expense 16.6m / Debt 709.7m)
Taxrate = 6.03% (26.6m / 440.3m)
NOPAT = 659.5m (EBIT 701.9m * (1 - 6.03%))
Current Ratio = 2.01 (Total Current Assets 1.16b / Total Current Liabilities 576.0m)
Debt / Equity = 0.17 (Debt 709.7m / totalStockholderEquity, last quarter 4.06b)
Debt / EBITDA = 0.21 (Net Debt 179.8m / EBITDA 841.3m)
Debt / FCF = 1.71 (Net Debt 179.8m / FCF TTM 105.0m)
Total Stockholder Equity = 3.70b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.18% (Net Income 784.7m / Total Assets 6.02b)
RoE = 21.24% (Net Income TTM 784.7m / Total Stockholder Equity 3.70b)
RoCE = 15.98% (EBIT 701.9m / Capital Employed (Equity 3.70b + L.T.Debt 696.7m))
RoIC = 17.85% (NOPAT 659.5m / Invested Capital 3.69b)
WACC = 7.61% (E(8.06b)/V(8.77b) * Re(8.09%) + D(709.7m)/V(8.77b) * Rd(2.34%) * (1-Tc(0.06)))
Discount Rate = 8.09% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF] Terminal Value 72.51% ; FCFF base≈121.8m ; Y1≈79.9m ; Y5≈36.6m
[DCF] Fair Price = 2.37 (EV 780.0m - Net Debt 179.8m = Equity 600.2m / Shares 253.7m; r=7.61% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 21.66 | EPS CAGR: -12.58% | SUE: 3.89 | # QB: 2
Revenue Correlation: 86.79 | Revenue CAGR: 30.23% | SUE: 4.0 | # QB: 2
EPS next Quarter (2026-06-30): EPS=0.84 | Chg7d=+0.230 | Chg30d=+0.230 | Revisions Net=+1 | Analysts=1
EPS current Year (2026-12-31): EPS=4.50 | Chg7d=+1.144 | Chg30d=+1.144 | Revisions Net=+2 | Growth EPS=+44.2% | Growth Revenue=+25.1%
EPS next Year (2027-12-31): EPS=3.07 | Chg7d=+0.132 | Chg30d=+0.132 | Revisions Net=+0 | Growth EPS=-31.7% | Growth Revenue=-10.3%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.3% (Discount Rate 8.1% - Earnings Yield 10.4%)
[Growth] Growth Spread = +18.3% (Analyst 16.0% - Implied -2.3%)
P/E Forward = 36.4964
P/S = 4.6525
P/B = 1.8944
P/EG = 1.1115
Revenue TTM = 1.74b USD
EBIT TTM = 701.9m USD
EBITDA TTM = 841.3m USD
Long Term Debt = 696.7m USD (from longTermDebt, two quarters ago)
Short Term Debt = 8.93m USD (from shortTermDebt, last quarter)
Debt = 709.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 179.8m USD (from netDebt column, last quarter)
Enterprise Value = 8.24b USD (8.06b + Debt 709.7m - CCE 529.8m)
Interest Coverage Ratio = 10.72 (Ebit TTM 701.9m / Interest Expense TTM 65.5m)
EV/FCF = 78.47x (Enterprise Value 8.24b / FCF TTM 105.0m)
FCF Yield = 1.27% (FCF TTM 105.0m / Enterprise Value 8.24b)
FCF Margin = 6.05% (FCF TTM 105.0m / Revenue TTM 1.74b)
Net Margin = 45.20% (Net Income TTM 784.7m / Revenue TTM 1.74b)
Gross Margin = 48.63% ((Revenue TTM 1.74b - Cost of Revenue TTM 891.9m) / Revenue TTM)
Gross Margin QoQ = 53.39% (prev 42.89%)
Tobins Q-Ratio = 1.37 (Enterprise Value 8.24b / Total Assets 6.02b)
Interest Expense / Debt = 2.34% (Interest Expense 16.6m / Debt 709.7m)
Taxrate = 6.03% (26.6m / 440.3m)
NOPAT = 659.5m (EBIT 701.9m * (1 - 6.03%))
Current Ratio = 2.01 (Total Current Assets 1.16b / Total Current Liabilities 576.0m)
Debt / Equity = 0.17 (Debt 709.7m / totalStockholderEquity, last quarter 4.06b)
Debt / EBITDA = 0.21 (Net Debt 179.8m / EBITDA 841.3m)
Debt / FCF = 1.71 (Net Debt 179.8m / FCF TTM 105.0m)
Total Stockholder Equity = 3.70b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.18% (Net Income 784.7m / Total Assets 6.02b)
RoE = 21.24% (Net Income TTM 784.7m / Total Stockholder Equity 3.70b)
RoCE = 15.98% (EBIT 701.9m / Capital Employed (Equity 3.70b + L.T.Debt 696.7m))
RoIC = 17.85% (NOPAT 659.5m / Invested Capital 3.69b)
WACC = 7.61% (E(8.06b)/V(8.77b) * Re(8.09%) + D(709.7m)/V(8.77b) * Rd(2.34%) * (1-Tc(0.06)))
Discount Rate = 8.09% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF] Terminal Value 72.51% ; FCFF base≈121.8m ; Y1≈79.9m ; Y5≈36.6m
[DCF] Fair Price = 2.37 (EV 780.0m - Net Debt 179.8m = Equity 600.2m / Shares 253.7m; r=7.61% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 21.66 | EPS CAGR: -12.58% | SUE: 3.89 | # QB: 2
Revenue Correlation: 86.79 | Revenue CAGR: 30.23% | SUE: 4.0 | # QB: 2
EPS next Quarter (2026-06-30): EPS=0.84 | Chg7d=+0.230 | Chg30d=+0.230 | Revisions Net=+1 | Analysts=1
EPS current Year (2026-12-31): EPS=4.50 | Chg7d=+1.144 | Chg30d=+1.144 | Revisions Net=+2 | Growth EPS=+44.2% | Growth Revenue=+25.1%
EPS next Year (2027-12-31): EPS=3.07 | Chg7d=+0.132 | Chg30d=+0.132 | Revisions Net=+0 | Growth EPS=-31.7% | Growth Revenue=-10.3%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.3% (Discount Rate 8.1% - Earnings Yield 10.4%)
[Growth] Growth Spread = +18.3% (Analyst 16.0% - Implied -2.3%)